Company registration number 09628935 (England and Wales)
HEALTHSPACE STUDIOS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
PAGES FOR FILING WITH REGISTRAR
HEALTHSPACE STUDIOS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
HEALTHSPACE STUDIOS LIMITED
BALANCE SHEET
AS AT 30 SEPTEMBER 2025
30 September 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
10,468
33,096
Current assets
Debtors
5
40,501
105,055
Cash at bank and in hand
121,891
89,217
162,392
194,272
Creditors: amounts falling due within one year
6
(27,938)
(39,050)
Net current assets
134,454
155,222
Total assets less current liabilities
144,922
188,318
Provisions for liabilities
-
0
(168)
Net assets
144,922
188,150
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
144,822
188,050
Total equity
144,922
188,150
HEALTHSPACE STUDIOS LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2025
30 September 2025
- 2 -

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 2 December 2025
Mrs C M Symes
Director
Company Registration No. 09628935
HEALTHSPACE STUDIOS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 3 -
1
Accounting policies
Company information

Healthspace Studios Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Old Coach House, The Square, Bishops Waltham, Southampton, Hampshire, SO32 1AF.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from a contract to provide beauty therapy services is recognised by reference to the stage of completion of the contract. The stage of completion of the contract is determined by reference to the hours worked as a proportion of total hours to be worked at the reporting date.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Leasehold
10% straight line basis
Fixtures, fittings & equipment
20% reducing balance basis
Computer equipment
20% straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets. A provision is made for any impairment loss and taken to the profit and loss account.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

HEALTHSPACE STUDIOS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Financial instruments

The company only enters into Basic financial instrument transactions.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Derivatives

Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period.

HEALTHSPACE STUDIOS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in the tax assessments.

Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

The company's liability for current and deferred tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
7
7
HEALTHSPACE STUDIOS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 6 -
4
Tangible fixed assets
Land and buildings Leasehold
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
£
Cost
At 1 October 2024
197,018
58,529
14,886
270,433
Additions
-
0
-
0
189
189
At 30 September 2025
197,018
58,529
15,075
270,622
Depreciation and impairment
At 1 October 2024
177,318
49,195
10,824
237,337
Depreciation charged in the year
19,700
1,867
1,250
22,817
At 30 September 2025
197,018
51,062
12,074
260,154
Carrying amount
At 30 September 2025
-
7,467
3,001
10,468
At 30 September 2024
19,700
9,334
4,062
33,096
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,163
1,468
Corporation tax recoverable
20,157
20,157
Other debtors
18,596
82,883
Prepayments and accrued income
585
547
40,501
105,055
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
370
2,342
Corporation tax
9,658
15,793
Other taxation and social security
12,590
15,375
Deferred income
1,286
1,632
Other creditors
1,023
1,047
Accruals and deferred income
3,011
2,861
27,938
39,050
HEALTHSPACE STUDIOS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2025
- 7 -
7
Directors' transactions

Dividends totalling £29,750 (2024 - £500) were paid in the year in respect of shares held by the company's director.

At the year end, the director was owed by the company £382 (202 4: owed the company £39,276).

2025-09-30 2024-10-01 false false false 02 December 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mrs C M Symes Mr R Symes 09628935 2024-10-01 2025-09-30 09628935 2025-09-30 09628935 2024-09-30 09628935 core:FurnitureFittings 2025-09-30 09628935 core:ComputerEquipment 2025-09-30 09628935 core:LandBuildings 2024-09-30 09628935 core:FurnitureFittings 2024-09-30 09628935 core:ComputerEquipment 2024-09-30 09628935 core:CurrentFinancialInstruments 2025-09-30 09628935 core:CurrentFinancialInstruments 2024-09-30 09628935 core:ShareCapital 2025-09-30 09628935 core:ShareCapital 2024-09-30 09628935 core:RetainedEarningsAccumulatedLosses 2025-09-30 09628935 core:RetainedEarningsAccumulatedLosses 2024-09-30 09628935 bus:Director1 2024-10-01 2025-09-30 09628935 core:LandBuildings core:LongLeaseholdAssets 2024-10-01 2025-09-30 09628935 core:FurnitureFittings 2024-10-01 2025-09-30 09628935 core:ComputerEquipment 2024-10-01 2025-09-30 09628935 2023-10-01 2024-09-30 09628935 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-09-30 09628935 core:FurnitureFittings 2024-09-30 09628935 core:ComputerEquipment 2024-09-30 09628935 2024-09-30 09628935 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-09-30 09628935 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-10-01 2025-09-30 09628935 bus:Director1 2025-09-30 09628935 bus:Director1 2024-09-30 09628935 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 09628935 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 09628935 bus:FRS102 2024-10-01 2025-09-30 09628935 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 09628935 bus:CompanySecretary1 2024-10-01 2025-09-30 09628935 bus:FullAccounts 2024-10-01 2025-09-30 xbrli:pure xbrli:shares iso4217:GBP